Sedative, hypnotic or anxiolytic-related dependence
ICD-10 F13.2 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic-related dependence.
Sedative, hypnotic, or anxiolytic-related dependence is characterized by a compulsive pattern of use of substances that induce sedation, relaxation, or anxiolysis. This condition often leads to significant impairment or distress, manifesting through a strong desire to consume these substances, tolerance (requiring increased amounts to achieve the desired effect), and withdrawal symptoms upon cessation. Patients may experience physical and psychological dependence, which can complicate treatment and recovery. Common substances involved include benzodiazepines, barbiturates, and other sedative-hypnotics. The clinical presentation may include anxiety, insomnia, and mood disturbances, alongside physical symptoms such as tremors, sweating, and seizures during withdrawal. Treatment typically involves a combination of medical detoxification, behavioral therapies, and support groups to address both the physical and psychological aspects of dependence.
Comprehensive substance use history, including duration and quantity of use, withdrawal symptoms, and previous treatment attempts.
Patients presenting with withdrawal symptoms, seeking detoxification, or requiring long-term management of dependence.
Consideration of co-occurring mental health disorders and the need for integrated treatment approaches.
Detailed mental health assessment, including evaluation of mood, anxiety levels, and any co-existing psychiatric conditions.
Patients with anxiety disorders who are using sedatives for self-medication or those experiencing exacerbation of psychiatric symptoms during withdrawal.
Importance of monitoring for potential exacerbation of psychiatric symptoms during treatment.
Used in conjunction with F13.2 for therapy sessions addressing dependence.
Document the nature of counseling and progress notes.
Ensure alignment with treatment goals and patient progress.
F13.2 indicates dependence, characterized by tolerance and withdrawal symptoms, while F13.10 refers to a milder use disorder without the criteria for dependence.
